Literature DB >> 15792779

Estrogen mediated inhibition of dopamine transport in the striatum: regulation by G alpha i/o.

Tina L Thompson1, Matthew E Certain.   

Abstract

In the current study, the interaction between estrogen priming and dopamine D2 receptor activation on dopamine uptake in the striatum of ovariectomized female rats was investigated. Basal ADP-[(32)P(i)]ribosylation of G(i/o) was examined in synaptosomal membranes prepared from ovariectomized, estrogen primed or N-p-(isothiocyanatophenethyl) spiperone (NIPS) treated rats. [(32)P(i)]-incorporation was significantly increased (141%) in tissue from NIPS treated animals but attenuated (57%) in tissue from estrogen primed animals. Dopamine uptake kinetics were measured in vivo following manipulation of the heterotrimeric G-protein by pertussis toxin (0.5 microg, 48 h). Pertussis toxin significantly inhibited dopamine uptake at all concentrations of dopamine examined. Co-treatment with estrogen and pertussis toxin resulted in a further attenuation of dopamine transport at high but not low dopamine concentrations. These data are consistent with an estrogen mediated alteration of G-protein activity and support the hypothesis that estrogen may alter transporter activity through a modulation of dopamine D2 autoreceptor/G alpha(i/o) protein coupling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15792779     DOI: 10.1016/j.ejphar.2005.02.005

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

Review 1.  Progesterone-estrogen interactions in synaptic plasticity and neuroprotection.

Authors:  M Baudry; X Bi; C Aguirre
Journal:  Neuroscience       Date:  2012-11-07       Impact factor: 3.590

Review 2.  Tamoxifen and amphetamine abuse: Are there therapeutic possibilities?

Authors:  Sarah Mikelman; Natalie Mardirossian; Margaret E Gnegy
Journal:  J Chem Neuroanat       Date:  2016-08-30       Impact factor: 3.052

3.  Scopolamine produces larger antidepressant and antianxiety effects in women than in men.

Authors:  Maura L Furey; Ashish Khanna; Elana M Hoffman; Wayne C Drevets
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

4.  Incidence of restless legs syndrome and its correlates.

Authors:  Pooja Budhiraja; Rohit Budhiraja; James L Goodwin; Richard P Allen; Anne B Newman; Brian B Koo; Stuart F Quan
Journal:  J Clin Sleep Med       Date:  2012-04-15       Impact factor: 4.062

5.  Elevated estradiol plasma levels in women with restless legs during pregnancy.

Authors:  Andrea Dzaja; Renate Wehrle; Marike Lancel; Thomas Pollmächer
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

6.  Evidence for the involvement of ERbeta and RGS9-2 in 17-beta estradiol enhancement of amphetamine-induced place preference behavior.

Authors:  Jill L Silverman; James I Koenig
Journal:  Horm Behav       Date:  2007-03-31       Impact factor: 3.587

7.  Restless legs syndrome is related to obstructive sleep apnea symptoms during pregnancy.

Authors:  Hasan Terzi; Rabia Terzi; Burak Zeybek; Mete Ergenoglu; Servet Hacivelioglu; Ali Akdemir; Ozgur Yeniel
Journal:  Sleep Breath       Date:  2014-03-05       Impact factor: 2.816

8.  17beta-estradiol-mediated neuroprotection and ERK activation require a pertussis toxin-sensitive mechanism involving GRK2 and beta-arrestin-1.

Authors:  Reymundo Dominguez; Eric Hu; Miou Zhou; Michel Baudry
Journal:  J Neurosci       Date:  2009-04-01       Impact factor: 6.167

Review 9.  Membrane estradiol signaling in the brain.

Authors:  Paul Micevych; Reymundo Dominguez
Journal:  Front Neuroendocrinol       Date:  2009-05-04       Impact factor: 8.606

10.  Pre-gestational stress alters stress-response of pubertal offspring rat in sexually dimorphic and hemispherically asymmetric manner.

Authors:  Yuejun Huang; Sihong Chen; Hongwu Xu; Xiaochan Yu; Huihong Lai; Guyu Ho; Qingjun Huang; Xuechuan Shi
Journal:  BMC Neurosci       Date:  2013-07-08       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.